# FDA 483 - Ravi Ganeshappa, M.D. - June 30, 2023

Source: https://www.keypedia.com/records/483/ravi-ganeshappa-md/f35e42b2-0d7e-4bda-b67f-5ff789b7fb15

> FDA 483 for Ravi Ganeshappa, M.D. on June 30, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ravi Ganeshappa, M.D.
- Inspection Date: 2023-06-30
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: Ravi Ganeshapp, M.D., a clinical investigator in San Antonio, TX, was cited for failing to conduct an investigation in accordance with the signed statement of investigator and investigational plan. The inspection revealed significant deviations, including errors in subject inclusion criteria and the incorrect dispensing of investigational drug product instead of a placebo to a study subject. These findings indicate a lack of adherence to study protocols and proper oversight in clinical trial conduct.

## Related Officers

- [Audrey J. Yarbrough](https://www.keypedia.com/people/audrey-j-yarbrough/1bab3d1a-3246-451e-96fb-4ce52185e850)
- [Habacuc V. Barrera](https://www.keypedia.com/people/habacuc-v-barrera/d4149e5b-7424-4ab8-b7f1-23988c83d9cf)

Company: https://www.keypedia.com/companies/ravi-ganeshappa-md/a42464aa-4b1f-462b-a29e-a93dbf5326db

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab